VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > JAMA Cardiology Study

<< Previous

Bullboard Posts

Next >>

Comment by GrahamBon Mar 05, 2021 8:50pm

181 Views

Post# 32734948

RE:RE:RE:RE:RE:RE:RE:JAMA Cardiology Study

G1945V wrote: GB... your best bet to get clear answers is to write to George Adams, Ph.D., ICD.D. I'm sure he'll answer all your concerns and perhaps you'll share it with us.

Have a good day.

G1945V.

Fair enough.
I think we have analyzed it enough.
'Time for a good break from the internet-off to the country for a while.
Take care and have a good weekend
G

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing